Dr. Kaczmar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
- SC State Medical License 2016 - 2025
- MO State Medical License 2016 - 2018
- PA State Medical License 2010 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck Cancer.Evan M Graboyes, Reid DeMass, Katherine R Sterba, Bhisham S Chera, Emily Kistner-Griffin
JCO Oncology Practice. 2025-01-06 - Disparities in Survival of Head and Neck Cancer in the Hispanic Population: Systematic-Review and Meta-analysis.Alejandro R Marrero-Gonzalez, Douglas P Nanu, Shaun A Nguyen, Emily A Brennan, William Greer Albergotti
Otolaryngology--Head and Neck Surgery. 2025-01-05 - 5 citationsPhase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20
Press Mentions
- Studies Show How to Boost Immunotherapy Effectiveness for Patients with Oral-Cavity Squamous Cell CarcinomaNovember 5th, 2021
- Clinical Trial Gets Oral Cancer Survivor Through 'Mean' CancerDecember 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: